Outlook Therapeutics, Inc. · NASDAQ:OTLK
Empery Asset Management, LP reported a 8.73% stake in Outlook Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 13, 2026
Empery Asset Management, LP reported a 8.73% stake in Outlook Therapeutics, Inc., 21,247,856 shares, as a passive investor on Sep 30, 2026. Filed Oct 13, 2026 (Schedule 13G).
- Stake
- 8.73%
- Shares
- 21,247,856
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 8.73% | 21,247,856 |
| Ryan M. Lane | 8.73% | 21,247,856 |
Source
Related
- Outlook Therapeutics, Inc.
- Empery Asset Management, LP
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G/A · Empery Asset Management, LP · Oct 21, 2025
- Schedule 13G · Empery Asset Management, LP · Jul 31, 2025
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026
- Schedule 13D/A · GMS Ventures & Investments · Aug 14, 2026